speb/financial-data huggingface dataset:
IKA.L — Peter Lynch category analysis (annual, as of 2025-04-30)
Sector: Industrials | Industry: Electrical Equipment & Parts
Lynch category: Turnaround (confidence: High)
Market cap (USD): 954668.7072
Net income (USD): -7869600
Revenue growth %: 290.0497512437811
Smoothed growth %: 290.0497512437811
P/B ratio: 0.04167766992054483
Pays dividend: no
Net asset value (USD): 16613866.666666666
Net cash (USD): 7614266.666666666
Net cash to market cap %: 797.5820941066524
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -4.698589218476342 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IKIO.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Technology | Industry: Electronic Components
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 287485.164183041
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IKIO.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Technology | Industry: Electronic Components
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 6094762.484774666
Pays dividend: no
Net asset value (USD): 17245432.39951279
Net cash (USD): -20193544.457978074
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 4 (Weak)
IKIO.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Technology | Industry: Electronic Components
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 258968222.3769194
Net income (USD): 7263580.765079746
EPS growth %: 19.177421322404385
Revenue growth %: 20.18399077271831
Smoothed growth %: 19.177421322404385
P/E ratio: 35.6529693483867
P/B ratio: 3.90649885565846
PEG ratio: 1.8591117517314197
Pays dividend: no
Net asset value (USD): 66219930.44729584
Net cash (USD): 9959227.725146899
Net cash to market cap %: 3.845733516543811
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 14.380281514680279 (Safe Zone)
Piotroski F-score: 5 (Neutral)
IKIO.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Technology | Industry: Electronic Components
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 212948058.35126618
Net income (USD): 3789922.8431143323
EPS growth %: -47.82294069978964
Revenue growth %: 8.154688611245415
EPS 2-year CAGR %: -21.143628161160954
Smoothed growth %: -47.82294069978964
P/E ratio: 56.18796665957405
P/B ratio: 3.2410213139763058
Pays dividend: no
Net asset value (USD): 64917114.80009352
Net cash (USD): -455927.0516717322
Net cash to market cap %: -0.21410246949500833
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 11.352781384492086 (Safe Zone)
Piotroski F-score: 6 (Neutral)
IKIO.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Technology | Industry: Electronic Components
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 167747293.59898263
Net income (USD): 4403878.762187367
EPS growth %: 16.199694413000838
Revenue growth %: 11.066723558062106
EPS 2-year CAGR %: -22.13499922267086
Smoothed growth %: 16.199694413000838
P/E ratio: 0.2344538097815711
P/B ratio: 1.3551320841325627
Pays dividend: no
Net asset value (USD): 63174226.36710471
Net cash (USD): -10738342.518016107
Net cash to market cap %: -6.401499712828293
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 7.776433634238889 (Safe Zone)
Piotroski F-score: 6 (Neutral)
ILMN — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 19731033000
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
ILMN — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Medium)
Market cap (USD): 20218219000
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 1 (Weak)
ILMN — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 12004142000
Net income (USD): 131000000
P/E ratio: 22.9086679389313
P/B ratio: 5.069316722972973
Pays dividend: no
Net asset value (USD): 977000000
Net cash (USD): -2577000000
Net cash to market cap %: -21.467590103482614
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.132108641713505 (Grey Zone)
Piotroski F-score: 4 (Weak)
ILMN — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 14435533000
Net income (USD): 235000000
P/E ratio: 39.441346994535515
P/B ratio: 6.393061558901683
Pays dividend: no
Net asset value (USD): 907000000
Net cash (USD): -2674000000
Net cash to market cap %: -18.523735839888975
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.583175230276169 (Grey Zone)
Piotroski F-score: 6 (Neutral)
ILMN — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 14368961000
Net income (USD): 150000000
P/E ratio: 27.84682364341085
P/B ratio: 6.034842923141537
Pays dividend: no
Net asset value (USD): 1043000000
Net cash (USD): -2518000000
Net cash to market cap %: -17.523883598821097
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 2.5654107097644423 (Grey Zone)
Piotroski F-score: 7 (Neutral)
ILMN — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 19844508000
Net income (USD): 334000000
P/E ratio: 23.346479999999996
P/B ratio: 7.287737054719059
Pays dividend: no
Net asset value (USD): 1400000000
Net cash (USD): -2288000000
Net cash to market cap %: -11.529638326130334
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.5410600322350776 (Safe Zone)
Piotroski F-score: 6 (Neutral)
ILMN — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 29365817344
Net income (USD): 134000000
EPS growth %: 2.2900763358778624
Revenue growth %: 4.803073967339097
Smoothed growth %: 2.2900763358778624
P/E ratio: 22.451730418943534
P/B ratio: 6.969072496263079
PEG ratio: 9.803922282938677
Pays dividend: no
Net asset value (USD): 962000000
Net cash (USD): -2728000000
Net cash to market cap %: -9.289712484564584
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.96844043963543 (Safe Zone)
Piotroski F-score: 5 (Neutral)
IMC.AX — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 16042140.670807453
P/B ratio: 2.4979744196923725
Pays dividend: no
Net asset value (USD): 6422059.627329192
Net cash (USD): 3668422.3602484474
Net cash to market cap %: 22.867411747136885
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IMC.AX — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 12660709.05882353
P/B ratio: 2.400638595225835
Pays dividend: no
Net asset value (USD): 5273892.156862745
Net cash (USD): 503097.38562091487
Net cash to market cap %: 3.973690440902242
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
IMC.AX — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 8233709.395973154
P/B ratio: 0.9875718641749485
Pays dividend: no
Net asset value (USD): 8776133.55704698
Net cash (USD): 5324955.033557047
Net cash to market cap %: 64.67261324721169
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
IMDA.PA — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Real Estate | Industry: REIT - Diversified
Lynch category:  (confidence: Low)
Market cap (USD): 468422895.2386364
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)
IMDA.PA — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Real Estate | Industry: REIT - Diversified
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 383998781.5
Net income (USD): 47182978.72340426
P/E ratio: 8.138502313537156
P/B ratio: 0.576670545566959
Pays dividend: no
Net asset value (USD): 661601063.8297873
Net cash (USD): -278044680.85106385
Net cash to market cap %: -72.40769873408149
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.6774998158540713 (Distress Zone)
Piotroski F-score: 3 (Weak)
IMDA.PA — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Real Estate | Industry: REIT - Diversified
Lynch category: Turnaround (confidence: High)
Market cap (USD): 371837617.3333333
Net income (USD): -28773333.333333332
EPS growth %: -160.98244348244347
Revenue growth %: 12.429195172506299
Smoothed growth %: -160.98244348244347
P/B ratio: 0.569475278097789
Pays dividend: no
Net asset value (USD): 648224444.4444444
Net cash (USD): -297074444.4444444
Net cash to market cap %: -79.89359618183343
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.712211637451297 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IMDA.PA — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Real Estate | Industry: REIT - Diversified
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 374035981.625
Net income (USD): 28437500
Revenue growth %: 0.9915430535455834
EPS 2-year CAGR %: -22.365809397501614
Smoothed growth %: 0.9915430535455834
P/E ratio: 13.152913639560438
P/B ratio: 0.5976189120600757
Pays dividend: no
Net asset value (USD): 621815625
Net cash (USD): -292877083.3333333
Net cash to market cap %: -78.30184734124464
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.6830202410070589 (Distress Zone)
Piotroski F-score: 6 (Neutral)
IMDA.PA — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Real Estate | Industry: REIT - Diversified
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 424746164.7058824
Net income (USD): 33262352.94117647
EPS growth %: 16.966515837104073
Revenue growth %: 30.83348644243591
Smoothed growth %: 16.966515837104073
P/E ratio: 14.508830827616407
P/B ratio: 0.5855917337426939
PEG ratio: 0.8551449789052769
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 748305882.3529412
Net cash (USD): -417620000
Net cash to market cap %: -98.32225331314835
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.6328335788840912 (Distress Zone)
Piotroski F-score: 6 (Neutral)
IMDX — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category:  (confidence: Low)
Market cap (USD): 1401393247.8
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMDX — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 207302872.14
Net income (USD): -72902000
P/B ratio: 6.045225479412108
Pays dividend: no
Net asset value (USD): -27341000
Net cash (USD): -45373000
Net cash to market cap %: -21.887299260069
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -2.536483127088974 (Distress Zone)
Piotroski F-score: 2 (Weak)
IMDX — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 80725417.5
Net income (USD): -27781000
Revenue growth %: 56.889352818371606
Smoothed growth %: 56.889352818371606
P/B ratio: 3.943981703146375
Pays dividend: no
Net asset value (USD): -36127000
Net cash (USD): -44992000
Net cash to market cap %: -55.734614193850405
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -5.440417172052661 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IMDX — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 76850597.46
Net income (USD): -60663000
Revenue growth %: 25.149700598802394
Smoothed growth %: 25.149700598802394
Pays dividend: no
Net asset value (USD): -26881000
Net cash (USD): -38719000
Net cash to market cap %: -50.38217174583824
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -14.99526642270162 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IMDX — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Healthcare | Industry: Diagnostics & Research
Lynch category: Turnaround (confidence: High)
Market cap (USD): 242176252.5
Net income (USD): -50222000
Revenue growth %: 115.57682083997874
Smoothed growth %: 115.57682083997874
Pays dividend: no
Net asset value (USD): -31464000
Net cash (USD): -45637000
Net cash to market cap %: -18.84453968086735
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -22.854295537660473 (Distress Zone)
Piotroski F-score: 4 (Weak)
IMM.AX — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 598353011.4586465
Net income (USD): -22483175.939849623
P/B ratio: 10.861089231953697
Pays dividend: no
Net asset value (USD): 45431851.879699245
Net cash (USD): 38623510.526315786
Net cash to market cap %: 6.454970525202268
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 49.958966356239344 (Safe Zone)
Piotroski F-score: 0 (Weak)
IMM.AX — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 294744261.2
Net income (USD): -22214362.75862069
P/B ratio: 4.542848050614001
Pays dividend: no
Net asset value (USD): 57602273.10344828
Net cash (USD): 49588237.93103448
Net cash to market cap %: 16.824157230116914
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 27.445489569214455 (Safe Zone)
Piotroski F-score: 5 (Neutral)
IMM.AX — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 302552056.1986755
Net income (USD): -26421422.516556293
Revenue growth %: -100
Smoothed growth %: -100
P/B ratio: 3.3476635911369104
Pays dividend: no
Net asset value (USD): 84092163.57615894
Net cash (USD): 74462327.81456953
Net cash to market cap %: 24.611410264444768
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 21.829624870175614 (Safe Zone)
Piotroski F-score: 3 (Weak)
IMM.AX — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Healthcare | Industry: Biotechnology
Lynch category: Speculative (confidence: Low)
Market cap (USD): 284919452.49333334
Net income (USD): -28477750
P/B ratio: 2.2550403675584616
Pays dividend: no
Net asset value (USD): 120853870
Net cash (USD): 113212610.66666667
Net cash to market cap %: 39.734953045831666
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Altman Z-score: 18.923943440849897 (Safe Zone)
Piotroski F-score: 4 (Weak)
IMOS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Semiconductors
Lynch category:  (confidence: Low)
Market cap (USD): 769132440.72
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMOS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 618922126.8000001
P/B ratio: 0.8109279286040356
Pays dividend: no
Net asset value (USD): 763227045.1770452
Net cash (USD): -153920787.5457875
Net cash to market cap %: -24.869168653187582
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
IMOS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 553552823.52
Net income (USD): 5311991.563724014
P/E ratio: 26.05203796351323
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
IMOS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Technology | Industry: Semiconductors
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 621703799.28
Net income (USD): -24386558.954967342
Pays dividend: no
Net asset value (USD): 799449982.8119628
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
IMOS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Semiconductors
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 655779287.16
Net income (USD): 11562705.187130664
P/E ratio: 14.178759999214648
P/B ratio: 0.8546859847544671
Pays dividend: no
Net asset value (USD): 767275114.9047931
Net cash (USD): -212899409.06106365
Net cash to market cap %: -32.46510117498107
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.40544135092535 (Distress Zone)
Piotroski F-score: 5 (Neutral)
IMOS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1017049000.5
Net income (USD): 23416613.316261206
P/E ratio: 63.946238034693074
P/B ratio: 1.3245700764485528
Pays dividend: no
Net asset value (USD): 767833290.653009
Net cash (USD): -204458802.8169014
Net cash to market cap %: -20.10314180697151
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 1.8427903970379302 (Grey Zone)
Piotroski F-score: 7 (Neutral)
IMOS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Semiconductors
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 1918310656
Net income (USD): 15758177.278401999
EPS growth %: 196.65290483546258
Revenue growth %: 29.86505435323653
Smoothed growth %: 196.65290483546258
P/E ratio: 45.87012987012987
P/B ratio: 1.5990626976675446
PEG ratio: 0.23325427055607914
Dividend yield: 0.01
Pays dividend: yes
Net asset value (USD): 768017665.4182272
Net cash (USD): -241527933.83270913
Net cash to market cap %: -12.590657987394776
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: no
Altman Z-score: 2.659747612469213 (Grey Zone)
Piotroski F-score: 6 (Neutral)
IMPPP — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
IMPPP — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Net income (USD): 31394604.255319152
Pays dividend: no
Net asset value (USD): 299632465.9574468
Net cash (USD): 36949431.91489363
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
IMPPP — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Net income (USD): 79037780
EPS growth %: 151.7559366482816
Revenue growth %: 97.785666149776
Smoothed growth %: 151.7559366482816
Pays dividend: no
Net asset value (USD): 402561636.6666667
Net cash (USD): 121664726.66666666
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 8 (Strong)
IMPPP — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Net income (USD): 52247679.16666667
EPS growth %: -33.89531036085949
Revenue growth %: -24.745209328770436
EPS 2-year CAGR %: 29.004837339325285
Smoothed growth %: 29.004837339325285
Pays dividend: no
Net asset value (USD): 438195487.5
Net cash (USD): 185306894.7916667
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
IMPPP — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Energy | Industry: Oil & Gas Midstream
Lynch category: Cyclical (confidence: High)
Net income (USD): 58797937.64705882
EPS growth %: 12.53693673071536
Revenue growth %: 23.298197738232577
EPS 2-year CAGR %: -13.749091161173666
Smoothed growth %: 12.53693673071536
Pays dividend: no
Net asset value (USD): 624487172.9411765
Net cash (USD): 191129721.17647058
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 5 (Neutral)
INA.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Technology | Industry: Solar
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): 20259794.553272814
Net cash (USD): -22137971.8107979
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
INA.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Technology | Industry: Solar
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 2161149.3181023425
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INA.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Technology | Industry: Solar
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 4956090.717792845
Pays dividend: no
Net asset value (USD): 72071229.83399579
Net cash (USD): 9600607.902735561
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 3 (Weak)
INA.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Technology | Industry: Solar
Lynch category:  (confidence: Low)
Pays dividend: no
Net asset value (USD): 77528680.9470124
Net cash (USD): -42237226.60653889
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INA.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Technology | Industry: Solar
Lynch category: Slow Grower (confidence: Low)
Net income (USD): 5649548.847053582
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INA.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Technology | Industry: Solar
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 262992652.47986436
Net income (USD): 7426229.334463756
EPS growth %: 243.62407411000015
Revenue growth %: 122.12455553624986
Smoothed growth %: 243.62407411000015
P/E ratio: 0.09528138036262114
P/B ratio: 2.2308979035457015
PEG ratio: 0.0003911000204339415
Pays dividend: no
Net asset value (USD): 85538353.115727
Net cash (USD): -86106983.89147946
Net cash to market cap %: -32.741212759954244
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 1.9833142157581982 (Grey Zone)
Piotroski F-score: 3 (Weak)
INDGN.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Health Information Services
Lynch category:  (confidence: Low)
Market cap (USD): 1982350220.4197326
P/B ratio: 7.032303409048305
Pays dividend: no
Net asset value (USD): 219624940.27711418
Net cash (USD): 97073578.59531774
Net cash to market cap %: 4.896893474996758
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 0 (Weak)
INDGN.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1686924766.5844502
Net income (USD): 12787038.116330573
P/E ratio: 32.98114761287147
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDGN.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1618410566.276345
Net income (USD): 13747954.173486087
P/E ratio: 29.43002547603711
P/B ratio: 5.292813879770552
Pays dividend: no
Net asset value (USD): 242331073.18213698
Net cash (USD): 112999766.19125554
Net cash to market cap %: 6.9821446143450805
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 12.756276330351863 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDGN.NS — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1617362349.9169202
Net income (USD): 13620407.20805055
P/E ratio: 40.2775808519306
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDGN.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1394487399.027515
Net income (USD): 11462626.71271026
P/E ratio: 27.01551185507669
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDGN.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Health Information Services
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 1255790973.124205
Net income (USD): 8446375.582874099
EPS growth %: -33.945801161825976
Revenue growth %: 26.633650962596988
Smoothed growth %: -33.945801161825976
P/E ratio: 0.2762262385689625
P/B ratio: 3.3157207639653237
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 161201780.41543028
Net cash (USD): -21195.42178890109
Net cash to market cap %: -0.001687814472512914
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 6.05640633526773 (Safe Zone)
Piotroski F-score: 2 (Weak)
INDIQUBE.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Real Estate | Industry: Real Estate Services
Lynch category:  (confidence: Low)
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDIQUBE.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Real Estate | Industry: Real Estate Services
Lynch category: Turnaround (confidence: Medium)
Net income (USD): -1599836.8108171115
Pays dividend: no
Net cash (USD): 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDIQUBE.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Real Estate | Industry: Real Estate Services
Lynch category: Turnaround (confidence: Medium)
Net income (USD): -3662613.9817629177
Pays dividend: no
Net asset value (USD): -1248655.5997194294
Net cash (USD): -547370002.3380874
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 1 (Weak)
INDIQUBE.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Real Estate | Industry: Real Estate Services
Lynch category: Turnaround (confidence: High)
Market cap (USD): 544931911.5219842
Net income (USD): -3367192.7846674183
P/B ratio: 8.782852124236156
Pays dividend: no
Net asset value (USD): 61360992.10822999
Net cash (USD): -559016685.4565953
Net cash to market cap %: -102.58468510226766
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 0.5760304641371813 (Distress Zone)
Piotroski F-score: 4 (Weak)
INDIQUBE.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Real Estate | Industry: Real Estate Services
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 495527052.9377298
Net income (USD): -1901191.9349448592
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 1 (Weak)
INDIQUBE.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Real Estate | Industry: Real Estate Services
Lynch category: Turnaround (confidence: High)
Market cap (USD): 407347286.8164477
Net income (USD): -2400593.471810089
Revenue growth %: 36.24445280601201
Smoothed growth %: 36.24445280601201
P/B ratio: 5.560302843990905
Pays dividend: no
Net asset value (USD): 54055637.98219585
Net cash (USD): -594670835.0996186
Net cash to market cap %: -145.98620252197227
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.1901807766847137 (Distress Zone)
Piotroski F-score: 2 (Weak)
INDOAMIN.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Basic Materials | Industry: Chemicals
Lynch category: Cyclical (confidence: High)
Net income (USD): 3039364.3676645127
Pays dividend: no
Net asset value (USD): 22745852.56494791
Net cash (USD): -47553013.31926678
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: no
Piotroski F-score: 2 (Weak)
INDOAMIN.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Basic Materials | Industry: Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 67379999.36175396
Net income (USD): 4978879.415347138
EPS growth %: 63.81317976603689
Revenue growth %: 11.585756079694637
Smoothed growth %: 63.81317976603689
P/E ratio: 13.533165546058136
P/B ratio: 2.4497607974357627
PEG ratio: 0.21207477194641935
Pays dividend: no
Net asset value (USD): 26164104.75030451
Net cash (USD): -44507990.25578563
Net cash to market cap %: -66.0551954250227
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.0052798286145856 (Safe Zone)
Piotroski F-score: 7 (Neutral)
INDOAMIN.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Basic Materials | Industry: Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 96551207.4472169
Net income (USD): 5153327.737138745
EPS growth %: 3.5037667563082375
Revenue growth %: -1.3152297716365178
EPS 2-year CAGR %: 30.212446218144116
Smoothed growth %: 30.212446218144116
P/E ratio: 18.735700962971258
P/B ratio: 3.0391847456621477
PEG ratio: 0.6201318763695313
Pays dividend: no
Net asset value (USD): 29862645.401127234
Net cash (USD): -43678522.60462885
Net cash to market cap %: -45.2387119327402
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 3.7501262060927627 (Safe Zone)
Piotroski F-score: 6 (Neutral)
INDOAMIN.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Basic Materials | Industry: Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 97085543.83942118
Net income (USD): 6534416.647182604
EPS growth %: 26.799943269485777
Revenue growth %: 11.458822195886025
EPS 2-year CAGR %: 14.561213998796173
Smoothed growth %: 14.561213998796173
P/E ratio: 14.857568637176024
P/B ratio: 2.609295910600188
PEG ratio: 1.0203523304035194
Pays dividend: no
Net asset value (USD): 35422808.04302081
Net cash (USD): -53323100.30395136
Net cash to market cap %: -54.923831288566916
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.9746375583947646 (Grey Zone)
Piotroski F-score: 5 (Neutral)
INDOAMIN.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Basic Materials | Industry: Chemicals
Lynch category: Cyclical (confidence: High)
Market cap (USD): 99596349.63967784
Net income (USD): 8406697.75328529
EPS growth %: 28.652612883354227
Revenue growth %: -2.5413782578483373
EPS 2-year CAGR %: 27.722918910743786
Smoothed growth %: 27.722918910743786
P/E ratio: 0.08243873812257739
P/B ratio: 1.5457854633770076
PEG ratio: 0.002973667325146954
Dividend yield: 0.00
Pays dividend: no
Net asset value (USD): 40246587.537091985
Net cash (USD): -51022774.48071217
Net cash to market cap %: -51.229562795527784
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.946278844826252 (Grey Zone)
Piotroski F-score: 7 (Neutral)
INDSWFTLAB.NS — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 134223274.3043478
Net income (USD): 540539.8948877209
P/E ratio: 62.078338515711316
P/B ratio: 1.1109195701201726
Pays dividend: no
Net asset value (USD): 120824844.7204969
Net cash (USD): 31289452.93836598
Net cash to market cap %: 23.311495789782295
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.364092057293409 (Safe Zone)
Piotroski F-score: 1 (Weak)
INDSWFTLAB.NS — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Turnaround (confidence: Medium)
Market cap (USD): 110052644.2715934
Net income (USD): -640191.1644713836
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
INDSWFTLAB.NS — Peter Lynch category analysis (quarterly, as of 2025-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 85205886.44742677
Net income (USD): 25984194.528875377
P/E ratio: 0.8197857196683573
P/B ratio: 0.62137507496711
Pays dividend: no
Net asset value (USD): 135880102.87584755
Net cash (USD): 21747790.507364973
Net cash to market cap %: 25.523812278842573
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.1237245331859724 (Grey Zone)
Piotroski F-score: 3 (Weak)
INDSWFTLAB.NS — Peter Lynch category analysis (quarterly, as of 2025-09-30)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 93363575.74227735
Net income (USD): 900811.7249154453
P/E ratio: 3.4856202502197635
P/B ratio: 0.6334007373281407
Pays dividend: no
Net asset value (USD): 146117609.9210823
Net cash (USD): 22150169.109357387
Net cash to market cap %: 23.7246366511295
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 2.6765363108827662 (Grey Zone)
Piotroski F-score: 4 (Weak)
INDSWFTLAB.NS — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 85392239.47532584
Net income (USD): 1062526.4564999444
EPS growth %: 96.56762924421123
Revenue growth %: -5.134982872253285
Smoothed growth %: 96.56762924421123
P/E ratio: 3.1270799221537167
PEG ratio: 0.03238227909940297
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
INDSWFTLAB.NS — Peter Lynch category analysis (quarterly, as of 2026-03-31)
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 209653299.87282747
Net income (USD): 1601536.6680796947
Revenue growth %: 19.85095981617874
Smoothed growth %: 19.85095981617874
P/E ratio: 0.28591442363541836
P/B ratio: 0.8221813605691055
Pays dividend: no
Net asset value (USD): 143765165.32428995
Net cash (USD): 19337876.218736753
Net cash to market cap %: 9.223740446950664
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 4.743697476820382 (Safe Zone)
Piotroski F-score: 3 (Weak)
INDUSINDBK.NS — Peter Lynch category analysis (annual, as of 2022-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category:  (confidence: Medium)
Market cap (USD): 9312090260.650402
Pays dividend: no
Net cash (USD): 124938190.68970065
Net cash to market cap %: 1.3416771873189979
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INDUSINDBK.NS — Peter Lynch category analysis (annual, as of 2023-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 9898781968.680145
Net income (USD): 906637978.0755178
P/E ratio: 10.918119699432703
P/B ratio: 1.4774942489253822
Pays dividend: no
Net asset value (USD): 6699709305.724727
Net cash (USD): -42150457746.65043
Net cash to market cap %: -425.8145889061396
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 2 (Weak)
INDUSINDBK.NS — Peter Lynch category analysis (annual, as of 2024-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 14332640473.631477
Net income (USD): 1076543950.1139226
EPS growth %: 18.740222243839494
Revenue growth %: 13.907353955786991
Smoothed growth %: 18.740222243839494
P/E ratio: 13.313567432258349
P/B ratio: 1.8909111897455753
PEG ratio: 0.7104274036363118
Pays dividend: no
Net asset value (USD): 7579753375.704521
Net cash (USD): -49105985657.75273
Net cash to market cap %: -342.61646169172826
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
INDUSINDBK.NS — Peter Lynch category analysis (annual, as of 2025-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 5899186947.107014
Net income (USD): 301091886.83656764
EPS growth %: -72.03162148608003
Revenue growth %: -11.590769499041471
EPS 2-year CAGR %: -42.372129307576515
Smoothed growth %: -72.03162148608003
P/E ratio: 19.59264664713163
P/B ratio: 0.7783004643910613
Pays dividend: no
Net asset value (USD): 7579575263.034837
Net cash (USD): -49601503869.53471
Net cash to market cap %: -840.8193250064655
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 4 (Weak)
INDUSINDBK.NS — Peter Lynch category analysis (annual, as of 2026-03-31)
Sector: Financial Services | Industry: Banks - Regional
Lynch category: Asset Play (confidence: Medium)
Market cap (USD): 7440816866.807969
Net income (USD): 94249682.06867316
EPS growth %: -68.69736907928316
Revenue growth %: -14.471070657580936
EPS 2-year CAGR %: -70.41142399384277
Smoothed growth %: -68.69736907928316
P/E ratio: 0.6934417540495769
P/B ratio: 0.8863971608002147
Dividend yield: 0.16
Pays dividend: yes
Net asset value (USD): 6966895930.479016
Net cash (USD): -45434711742.26367
Net cash to market cap %: -610.6145676684915
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 5 (Neutral)
ING.AX — Peter Lynch category analysis (annual, as of 2021-06-30)
Sector: Consumer Defensive | Industry: Farm Products
Lynch category: Turnaround (confidence: Low)
Market cap (USD): 880293791.8421052
Net income (USD): 62631578.94736842
P/E ratio: 14.055110962184873
Pays dividend: no
Net asset value (USD): 123007518.79699248
Net cash (USD): -1971127819.5488722
Net cash to market cap %: -223.91704199391032
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.207218728147525 (Distress Zone)
Piotroski F-score: 1 (Weak)
ING.AX — Peter Lynch category analysis (annual, as of 2022-06-30)
Sector: Consumer Defensive | Industry: Farm Products
Lynch category: Slow Grower (confidence: Low)
Market cap (USD): 545984517.3310345
Net income (USD): 24206896.55172414
EPS growth %: -61.35033323674296
Revenue growth %: -6.753312866947807
Smoothed growth %: -61.35033323674296
P/E ratio: 22.554915958119654
P/B ratio: 5.00428287060682
Pays dividend: no
Net asset value (USD): 109103448.27586207
Net cash (USD): -1553862068.9655173
Net cash to market cap %: -284.5981927402163
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.0444446358458983 (Distress Zone)
Piotroski F-score: 4 (Weak)
ING.AX — Peter Lynch category analysis (annual, as of 2023-06-30)
Sector: Consumer Defensive | Industry: Farm Products
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 541519948.4768212
Net income (USD): 40000000
EPS growth %: 65.24216524216523
Revenue growth %: 7.738246198661818
EPS 2-year CAGR %: -20.08407779516813
Smoothed growth %: 65.24216524216523
P/E ratio: 13.53799871192053
P/B ratio: 4.052007543111989
Pays dividend: no
Net asset value (USD): 133642384.10596026
Net cash (USD): -1480927152.3178806
Net cash to market cap %: -273.47601071454693
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.2902373300039458 (Distress Zone)
Piotroski F-score: 7 (Neutral)
ING.AX — Peter Lynch category analysis (annual, as of 2024-06-30)
Sector: Consumer Defensive | Industry: Farm Products
Lynch category: Fast Grower (confidence: Medium)
Market cap (USD): 550085845.3333334
Net income (USD): 67666666.66666667
EPS growth %: 69.16666666666667
Revenue growth %: 7.876040297853694
EPS 2-year CAGR %: 67.19290142467061
Smoothed growth %: 67.19290142467061
P/E ratio: 14.400000000000002
P/B ratio: 4.506893365419164
PEG ratio: 0.21430835244023091
Dividend yield: 0.04
Pays dividend: yes
Net asset value (USD): 146400000
Net cash (USD): -1379800000
Net cash to market cap %: -250.83357656001638
Cyclical industry: no | Hot industry: no | Large cap: no | Small cap: no
Altman Z-score: 1.966512975202602 (Grey Zone)
Piotroski F-score: 7 (Neutral)
INGR — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Consumer Defensive | Industry: Packaged Foods
Lynch category:  (confidence: Medium)
Market cap (USD): 5368848453.54
Pays dividend: no
Net cash (USD): 0
Net cash to market cap %: 0
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Piotroski F-score: 0 (Weak)
INGR — Peter Lynch category analysis (annual, as of 2022-12-31)
Sector: Consumer Defensive | Industry: Packaged Foods
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 5609103475.95
Net income (USD): 502000000
P/E ratio: 11.173512900298805
P/B ratio: 1.719528962584304
Pays dividend: no
Net asset value (USD): 1894000000
Net cash (USD): -4060000000
Net cash to market cap %: -72.38233377950597
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.1740922032628767 (Safe Zone)
Piotroski F-score: 3 (Weak)
INGR — Peter Lynch category analysis (annual, as of 2023-12-31)
Sector: Consumer Defensive | Industry: Packaged Foods
Lynch category: Fast Grower (confidence: High)
Market cap (USD): 6399233510.280001
Net income (USD): 651000000
EPS growth %: 29.681274900398407
Revenue growth %: 2.693178957966272
Smoothed growth %: 29.681274900398407
P/E ratio: 9.829851782304146
P/B ratio: 1.753214660350685
PEG ratio: 0.33118024125615314
Pays dividend: no
Net asset value (USD): 2290000000
Net cash (USD): -3583000000
Net cash to market cap %: -55.9910807168408
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.555684592534187 (Safe Zone)
Piotroski F-score: 9 (Strong)
INGR — Peter Lynch category analysis (annual, as of 2024-12-31)
Sector: Consumer Defensive | Industry: Packaged Foods
Lynch category: Stalwart (confidence: Medium)
Market cap (USD): 8268934668.929999
Net income (USD): 654000000
EPS growth %: 0.4608294930875576
Revenue growth %: -8.946078431372548
EPS 2-year CAGR %: 14.139775916264785
Smoothed growth %: 14.139775916264785
P/E ratio: 12.643630992247706
P/B ratio: 2.125690146254499
PEG ratio: 0.8941889225913344
Pays dividend: no
Net asset value (USD): 2600000000
Net cash (USD): -2546000000
Net cash to market cap %: -30.789939719398614
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 4.133849463928639 (Safe Zone)
Piotroski F-score: 8 (Strong)
INGR — Peter Lynch category analysis (annual, as of 2025-12-31)
Sector: Consumer Defensive | Industry: Packaged Foods
Lynch category: Slow Grower (confidence: Medium)
Market cap (USD): 6791460869.7
Net income (USD): 736000000
EPS growth %: 12.538226299694188
Revenue growth %: -2.8398384925975773
EPS 2-year CAGR %: 6.328188001809187
Smoothed growth %: 6.328188001809187
P/E ratio: 9.227528355570652
P/B ratio: 1.5555338684608337
PEG ratio: 1.4581628031487943
Pays dividend: no
Net asset value (USD): 3069000000
Net cash (USD): -2498000000
Net cash to market cap %: -36.78148262835157
Cyclical industry: no | Hot industry: no | Large cap: yes | Small cap: no
Altman Z-score: 3.8287029615909955 (Safe Zone)
Piotroski F-score: 8 (Strong)
ININ.OL — Peter Lynch category analysis (quarterly, as of 2024-09-30)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 46007583.625954196
Net income (USD): -439599.23664122133
P/B ratio: 1.2596518982579705
Pays dividend: no
Net asset value (USD): -10392080.152671756
Net cash (USD): -62517080.15267175
Net cash to market cap %: -135.88429390454678
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: 0.5464243161678285 (Distress Zone)
Piotroski F-score: 2 (Weak)
ININ.OL — Peter Lynch category analysis (quarterly, as of 2024-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 26430401.72839506
Net income (USD): -6374227.714033539
P/B ratio: 1.645437445507033
Pays dividend: no
Net asset value (USD): -21871579.876434244
Net cash (USD): -72024889.67343336
Net cash to market cap %: -272.50773716411067
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Altman Z-score: -0.19752487831934257 (Distress Zone)
Piotroski F-score: 6 (Neutral)
ININ.OL — Peter Lynch category analysis (quarterly, as of 2025-06-30)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 31187212.166832175
P/B ratio: 1.769434874949998
Pays dividend: no
Net asset value (USD): -39798709.0367428
Net cash (USD): -110952035.74975175
Net cash to market cap %: -355.76131382384364
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
ININ.OL — Peter Lynch category analysis (quarterly, as of 2025-12-31)
Sector: Industrials | Industry: Engineering & Construction
Lynch category: Cyclical (confidence: High)
Market cap (USD): 37343535.12437811
P/B ratio: 3.0001339591022367
Pays dividend: no
Net asset value (USD): -19548457.711442783
Net cash (USD): -108920497.5124378
Net cash to market cap %: -291.67162977383407
Cyclical industry: yes | Hot industry: no | Large cap: no | Small cap: yes
Piotroski F-score: 2 (Weak)
INKT — Peter Lynch category analysis (annual, as of 2021-12-31)
Sector: Healthcare | Industry: Biotechnology
Lynch category:  (confidence: Low)
Market cap (USD): 222192695.4
Pays dividend: no
Net cash (USD): 38888828
Net cash to market cap %: 17.502298142605817
Cyclical industry: no | Hot industry: yes | Large cap: no | Small cap: yes
Piotroski F-score: 0 (Weak)